Molecular Therapy - Nucleic Acids
Volume 7, 16 June 2017, Pages 475-486
Original ArticleEvaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
Under a Creative Commons license
open access
Keywords
hypertrophic cardiomyopathy
MYBPC3
trans-splicing
gene replacement
human induced pluripotent stem cell-derived cardiomyocytes
Cited by (0)
© 2017 The Author(s).